RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

… (RVAC), a messenger RNA (mRNA) technology platform company, announced today that … Professor Barnaby Young, Head of Singapore Infectious Disease Clinical Research Network, …  and Shanghai. Leveraging its mRNA technology and strategic partnerships, the company …